1. Paradisi F, Giampaolo C, Messeri D. Antistaphylococcal antibiotics. Med Clin North Am. 2001;85:16-32.
2.
2. Daum RS, Seal JB. Evolving antimicrobial chemotherapy for Staphylococcus aureus infections: otir backs to the wall. Crit Care Med. 2001;29:481-491.
3.
3. Fridkin SK. VTancomycin-intermediate and resistant Staphylococcus aureus: what the infectious disease specialist needs to know. Cliii Infect Dis. 2001;32:108-115.
4.
4. Hussain FM, Boyle-Vavra S, Bethel CD, et al. Current trends in community-acquired methicillin-resistant Staphylococcus auieus at a tertiary care pediatric facility. Pediatr Infect Dis J. 2000;19:1163-1166.
5.
5. Von Eiff C, Becker K, Machka K, et al. Nasal carriage as a source of Staphylococcus aureus bacteremia. NEngl JMed. 2001;344:11-16.
6.
6. Todd JK, Fishant M, Keprol F, et al. Toxic-shock syndrome associated with phage-group-l staphvlococci. Lancet. 1978;2:1116-1118.
